Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 protein.

Maertens, G; Priem, S; Ducatteeuw, A; Verschoorl, E; Verstrepen, B; Roskams, T; Desmet, V; Fuller, S; Van Hoek, K; Vandeponseele, P; Bosman, F; Buyse, M A; van Doorn, L J; Heeney, J; Kos, A; Depla, E

Maertens, G; Priem, S; Ducatteeuw, A; Verschoorl, E; Verstrepen, B; Roskams, T; Desmet, V; Fuller, S; Van Hoek, K; Vandeponseele, P; Bosman, F; Buyse, M A; van Doorn, L J; Heeney, J; Kos, A; Depla, E.

Affiliation

Maertens G; Hepatitis Program, Innogenetics, Gent, Belgium.

Acta Gastroenterol Belg ; 63(2): 203, 2000.

Article in En | MEDLINE | ID: mdl-11023431

Subject(s)

Hepatitis C, Chronic/immunology; Hepatitis C, Chronic/therapy; Immunotherapy/methods; Viral Envelope Proteins/administration & dosage; Animals; Disease Models, Animal; Follow-Up Studies; Pan troglodytes; Treatment Outcome; Viral Envelope Proteins/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Viral Envelope Proteins / Hepatitis C, Chronic / Immunotherapy Type of study: Observational_studies / Prognostic_studies Limits: Animals Language: En Journal: Acta Gastroenterol Belg Year: 2000 Document type: Article Affiliation country: Belgium Country of publication: Belgium

Search on Google

Add to My VHL

XML

PubMed Links